Bennett, C., Hoosain, Z., Koen, A., Lalloo, U., Louw, C., Maluleke, V., Patel, F., Benade, G., Venter, E.L., Galbiati, S. and Shinde, V., 2024. Immunogenicity and safety of SARS-CoV-2 recombinant spike protein vaccine in South African people living with and without HIV-1 infection: A phase 2 randomised trial. Journal of Infection, 89(6), p.106285.
Immunogenicity and Safety of SARS-CoV-2 Recombinant Spike Protein Vaccine in South African People Living With and Without HIV-1 Infection: A Phase 2 Randomised Trial
- Journal Articles
